Document Detail


Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
MedLine Citation:
PMID:  9239517     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cepharanthin (CE), a bisbenzylisoquinoline alkaloid drug, was tested in vitro and in vivo with chemotherapeutic agents, vincristine (VCR), vinblastine (VLB), and vindesine (VDS). The activity of these agents alone or in combination was tested against a human colon cancer cell line (RPMI 4788) or a human uterine cervical cancer cell line (HeLa), using a modified microcytotoxicity-viable cell staining assay. In the in vitro study, the antiproliferative activities of each vinca alkaloid were enhanced additively or synergistically by combination with CE in RPMI 4788 cells as well as HeLa cells. The sequential exposure of the RPMI 4788 cells or HeLa cells to both CE and each vinca alkaloid agent showed evidence of a more significant potentiation. The antiproliferative activity of the combination of each vinca alkaloid agent(VCR, VLB, or VDS) with CE was almost equivalent to the effect of each vinca alkaloid agent alone which was potentiated by CE tenfold through several hundredfold. In an experimental model of tumor growth and survival, in which RPMI 4788 cells were transplanted subcutaneously or intraperitoneally into BALB/c nu/nu mice respectively, CE (1 mg/kg) alone exerted not significant inhibitory activity against tumor growth or survival, and VCR (0.25 mg/kg) alone partially inhibited these antitumor activities. Furthermore, the antitumor effects of VCR were elevated synergistically by the simultaneous administration of CE. These studies indicate that due to their therapeutic potential, combinations of vinca alkaloid agent with CE might be a promising therapy for some human cancers.
Authors:
M Ono; N Tanaka
Related Documents :
22568867 - Nestin expression identifies ependymoma patients with poor outcome.
22432057 - Tumor growth is suppressed in mice expressing a truncated xrcc1 protein.
22385197 - Chemotherapy targeting by dna capture in viral protein particles.
22700727 - Cd38 deficiency in the tumor microenvironment attenuates glioma progression and modulat...
23622307 - Acute myelopathy: tumoral or traumatic spinal cord compression.
20123457 - Desmoplastic nested spindle cell tumor of the liver in an adult.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  11     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    1997 May-Jun
Date Detail:
Created Date:  1997-09-09     Completed Date:  1997-09-09     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  233-41     Citation Subset:  IM    
Affiliation:
First Department of Surgery, Okayama University Medical School 2-5-1, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkaloids / pharmacology*
Animals
Antineoplastic Agents, Phytogenic / pharmacology*
Benzylisoquinolines
Body Weight
Cell Division / drug effects
Cell Survival / drug effects
Colonic Neoplasms
Drug Interactions
Hela Cells
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Tumor Cells, Cultured / cytology,  drug effects
Vinca Alkaloids / pharmacology*
Chemical
Reg. No./Substance:
0/Alkaloids; 0/Antineoplastic Agents, Phytogenic; 0/Benzylisoquinolines; 0/Vinca Alkaloids; 481-49-2/cepharanthine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lack of carcinogenesis by the baked mushroom Agaricus bisporus in mice: different feeding regimen [c...
Next Document:  Cell proliferation in aortic, mammary artery and saphenous vein biopsies in patients subjected to op...